| Literature DB >> 35711631 |
Shilpa Maddheshiya1, Seema Nara1.
Abstract
Nanozymes are inorganic nanostructures whose enzyme mimic activities are increasingly explored in disease treatment, taking inspiration from natural enzymes. The catalytic ability of nanozymes to generate reactive oxygen species can be used for designing effective antimicrobials and antitumor therapeutics. In this context, composite nanozymes are advantageous, particularly because they integrate the properties of various nanomaterials to offer a single multifunctional platform combining photodynamic therapy (PDT), photothermal therapy (PTT), and chemodynamic therapy (CDT). Hence, recent years have witnessed great progress in engineering composite nanozymes for enhanced pro-oxidative activity that can be utilized in therapeutics. Therefore, the present review traverses over the newer strategies to design composite nanozymes as pro-oxidative therapeutics. It provides recent trends in the use of composite nanozymes as antibacterial, antibiofilm, and antitumor agents. This review also analyzes various challenges yet to be overcome by pro-oxidative composite nanozymes before being used in the field.Entities:
Keywords: antibacterial; antitumor; nanozyme; pro-oxidative; therapeutic
Year: 2022 PMID: 35711631 PMCID: PMC9197165 DOI: 10.3389/fbioe.2022.880214
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Advantages of composite nanozymes in therapeutics over other therapeutic remedies.
SCHEME 1(A) Reaction catalyzed by peroxidase mimic nanozymes (Bhaskar et al., 2015). (B) Schematic for POD-catalyzed two-electron oxidation of TMB into TMBDI. Adapted and reprinted with permission from Liu et al. (2021).
SCHEME 2Reaction catalyzed by glutathione peroxidase mimic nanozymes (Barrington, 2013).
SCHEME 3(A) Reaction catalyzed by haloperoxidase mimic nanozymes, (B) Fabrication of ceria nanofibrous mat. The hybrid mat can catalyze Br− with H2O2 to HOBr to prevent bacterial adhesion on its surface. Adapted and reprinted with permission from Hu et al. (2018), Herget et al. (2017).
SCHEME 4(A) Reaction catalyzed by oxidase mimic nanozymes (Li et al., 2020). (B) Equations 1–4 represent proposed mechanism of oxidase mimic nanoceria. Adapted and reprinted with permission from (Cheng et al. (2016).
SCHEME 5Reaction catalyzed by DNase mimic nanozymes (Laukova et al., 2020).
SCHEME 6Depiction of various cleavage sites of a phospholipid by different phospholipases, PLA -cleaves sn-1 acyl chain; PLA -cleaves the sn-2acyl chain; PLC-cleaves before phosphate, releasing diacylglycerol and phosphate-containing group; PLD- cleaves after phosphate, releasing phosphatidic acid and alcohol. Adapted and reprinted with permission from Khulbe et al. (2020).
Comparison of various pro-oxidative enzyme mimic activities exhibited by composite nanozymes.
| Enzyme activity displayed | Nanozyme mimic | Substrate | Mechanism of action | Therapeutic applications |
|---|---|---|---|---|
| Peroxidase | Broad range including metal, metal oxide, metal organic framework–based, and carbon-based nanozymes | H2O2 | Generated ROS (•OH, •O2) cause oxidative stress–mediated cell killing | Antibacterial, anticancer, antibiofilm, and wound healing |
| Oxidase | Most nanoparticles such as Au, NiO, Pd, V2O5, IrOx, etc | O2 | Generates ROS (H2O2 or •O2) that causes oxidative damage | Antibacterial; anticancer |
| Glutathione peroxidase | Few nanoparticles such as NiS2, PdFe/GD | Glutathione and H2O2 | Deplete glutathione by converting into glutathione disulphide and weakens bacterial defense system | Antibacterial; anticancer |
| Haloperoxidase | Nanoparticles such as CeO2 and V2O5 | Halide ions (Cl and, Br−) | Generate hypohalous acid which causes oxidative cell damage | Antibiofilm; antibiofouling |
| DNase | Nanoparticles such as CeO2 and MOF/Ce | DNA | Cleaves DNA of biofilm into fragments | antibiofilm |
| Phospholipase | Nanoparticles such as Nanoceria | Phospholipids | Hydrolysis of long-chain phospholipids present on the bacterial cell membrane and disrupt it | antibiofilm; antibacterial |
FIGURE 2Nanomaterial-based composite nanozymes with pro-oxidative enzyme-like activity.
Advantages and disadvantages of different composite nanozymes.
| Composite nanozymes | Advantages | Disadvantages |
|---|---|---|
| Metal-based | Easy synthesis, facile surface modification, tunability of shape-size, electromagnetic functionality, high catalytic activity, easy to hybridize with other elements, positive synergistic coupling effect, and ability to stabilize free radicals (Au NPs) | Only few metals are biodegradable and releases in the form of ions cause toxicity |
| Metal-oxide based | High stability, easy to prepare, adjustable porosity, facile incorporation into hydrophobic and hydrophilic systems, and good redox chemistry | Toxic, traditional method of synthesis is not feasible |
| Metal-organic framework–based | Porous structure provide abundant surfaces and channel for electron transfer, adsorption, loading, and separation of targets, metal nodes in MOF provide the possible active sites for catalysis, and organic ligands offer rich functional groups for chemical modification | Toxic, poor selectivity, and difficulties in recycling and regeneration |
| Carbon-based | Excellent transportation property (e.g., graphene), rich surface chemistry, low cost non-toxicity (graphitic carbon nitride), long-term storage, and high stability | Low catalytic activity, catalytic mechanism unknown, difficulties in rational design, and construction |
| Hydrogel- based | Flexile, biocompatible, capture target cells with high efficiency due to charge and pore. Biodegradable, diversiform structure and properties, easily transportable, and easy to tune | limited nanozyme type, low mechanical strength, and difficult to handle and are expensive, non-adherent |
FIGURE 3Engineering composite nanozymes with enhanced pro-oxidative (A). Defect-rich surface of composite nanozymes enhance the affinity of composite nanozymes to bacteria. Adapted and reprinted with permission from reference (Wang et al., 2020). (B). Multicatalytic action of composite nanozymes perform cascade reaction and exert superior activity. Adapted and reprinted with permission from the reference (Wei et al., 2020) (C). Conjugation of CXCR4 to Fe3O4@Pt@E5 specifically target cancerous cells and synergistically treat AML (Kong et al., 2021) (D). Multifunctionality such as photothermal/chemodynamic/pharmaco of WS2QDs synergistically kill and eradicate bacteria Adapted and reprinted with permission from reference (Xu et al., 2020).
FIGURE 4Schematic representation of composite nanozymes as effective antibacterial and antibiofilm agents. (A). Mechanism of enzyme mimic Pd@Ir nanostructures for potential antibacterial therapy. Adapted and reprinted with permission from the reference (Cai et al., 2019). HA: humic acid. (B). Dual-catalytic activity of Dex-IONP-GOx for the disruption and inhibition of the bacterial biofilm. Adapted and reprinted with permission from the reference (Huang et al., 2021).
Various composite nanozymes with demonstrated use as antibacterial and wound healing agent through ROS.
| S. no. | Nanozyme used | Structural property of nanozymes leading to catalytic action | Catalytic property shown | Working pH of nanozymes | Km | Vmax | ROS species generated | Demonstrated application | Mechanism of action | Other specific property of nanozymes | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CuCo2S4 | Uniform, well-crystallized cubic spinel, size -30 nm | POD | 7.4 | 209.9 mM | 232.8 n M·s −1 | •OH | AB, WH | Oxidative stress | Antibiofilm | Li et al. (2020) |
| 2 | Dealloyed porous Pt/Ag nanoparticles | Porous, Pt-enriched octahedron, size range - 20.9–22.1 nm | POD, OXD, CAT- | 4.0 | 0.86 mM | 34.75 (×10–8 M s−1) | •OH | AB | Oxidative stress, disrupts permeability of the membrane | As biosensors, and biomedicine |
|
| 3 | Cu2WS4 nanocrystals | Cuboid, size ∼20 nm | POD | 4 | — | — | H2O2 and •OH | AB, WH | oxidative stress | Selective and good bacteria-binding ability |
|
| 4 | Cu2MoS4 | Uniform morphology, size is ≈ 28 nm | POD, OXD | 4 | OXD-12.06 µm, POD- 25.46 | OXD- 0.11 μm s−1 | H2O2, •OH | AB | Oxidative stress | Enhanced activity under NIR-II |
|
| OXD-42.81 × 10–8 | |||||||||||
| 5 | (MoS2)/rGO | Defect-rich surface | POD, OXD | 3.0 | POD-0.26 mM | POD | •OH | AB,WH | Structural deformation. Causes oxidative stress through GSH (antioxidant) consumption and ROS generation | Defect and light irradiated improved activity, Also, GSH consumption ability |
|
| 6 | CuS/GO | Needle-like | POD, OXD | 4.6 | — | — | •OH | AB, WH | Nanoknife mechanism (puncture bacterial membranes), and though generation of ROS | Good biocompatibility |
|
| 7 | UsAuNPs/MOFs | 2D ultrathin morphology | POD | pH 5.0 | 7.94 × 10–3 m | - | •OH | AB,WH | Oxidative stress | Negligible biological toxicity |
|
| 8 | Fe/N-HCNs | Hollow porous | POD, OXD | 3.5 | — | — | •OH | WH | ROS destroyed bacterial cells treat bacteria-infected inflammation | CAT and SOD activity treat noninfectious inflammation |
|
| 9 | Pd@Ir | Octahedral core shell structured, size ∼14 nm | POD, OXD | 4.0 | 0.28 mM | 0.079 (10–7 Ms−1) | H2O2, •OH | AB | Oxidative stress, damage membrane | Biocompatible |
|
| 10 | Au@CeO2 | Uniform dumbbell-shape size ∼20 nm | POD | 3.0 | 0.006 mM | 13.34 nM S−1 | OH and 1O2 | AB | Oxidative stress | Good catalytic stability and durability |
|
| 11 | NSP-CQDs | Spherical nature and excellent dispersibility, size 2–6 nm | POD | 4.0 | 32.61 mM | 6,950.68 10−8 Ms−1 | •OH | AB | •OH, attacking the bacterial cell membrane | Applicable in immunoassays, biotechnology, and clinical diagnosis |
|
| 12 | L-Arg/GOx@CuBDC | Sea urchin–like, Size-250 ± 50 nm | GOx, POD, NOS | 7.4 | — | — | •OH, •O2 | AB | ROS and RNS oxidize and degrade organics, including penetrating cell membrane, reacting with biological substrates (lipids, proteins, DNA, and RNA) | High specificity |
|
| 13 | Co-Al-Ce mixed metal oxide | Good dispersion of catalytically active components and high specific surface area | POD | 4 | 32.9 mmol/L | — | •O2 | AB | Oxidative stress | Application in marine antifouling |
|
| 14 | Nickel disulfide | Monodispersed and uniform spherical, porous, diameter -112.31 nm | POD | — | ∼3.64 mM | ∼1.55 × 10̵4 mM min̵1 | •OH | AB | Cell wall damage by ROS, consume GSH in bacteria | Photothermal activity |
|
| 15 | MoS2-Hydrogel | Positively charged porous, Flower like diameter- 165 nm | POD | 4 | — | — | • OH | AB | Damage membrane and causes oxidative stress | Photothermal properties under visible and NIR region |
|
| 16 | Hydrogel-based artificial enzyme (copper and L-aspartic acid) | Network nanofiber diameters -50–70 nm | POD | 7.4 | 38 Mm | 9.6 × 10−8M S−1 | • OH | WH, AB | ROS Oxidize cell membrane of bacteria | Negligible toxicity and high biocompatibility |
|
| 17 | WS2QDs-Van@ lipo | Spherical uniform size less than 10 nm | POD, OXD | 2–4 | — | — | • OH | AB and antibiofilm | ROS and drug mediated | Oxidize GSH improve CDT PTT/pharmaco synergistic antibacterial therapy, NIR-controlled drug release |
|
| 18 | GQD/AgNP hybrids | Size-2–10 nm | OXD, POD | 5–7 | — | — | OH,•O2 − | AB | ROS-mediated oxidative stress and disruption of bacterial membrane | Photothermal activity |
|
| 19 | CaO2/H-G@alginate | 2D nanosheet | POD | 5 | 2.568 mM | 0.185 μM S−1 | hROS | Antibiofilm | hROS can damage the main component of biofilm | No need of H2O2 |
|
| 20 | Au/g-C3N4 | Size- 150 nm | POD | 5.0–7.4 | 60.0 ± 3.21 (10−5 M) | 150.8 ± 4.95 (10−7M·S−1) | •OH | AB, WH | ROS-mediated oxidative stress | Antibiofilm |
|
| 21 | 2D MOF (2D Cu-TCPP(Fe) GOx (MOF (2D Cu-TCPP(Fe)/GOx | Sheet-like structure, Crystal size 13.6 | POD | 3–4 | — | — | •OH | AB, WH | •OH-induced oxidative damage | GOx convert glucose into abundant gluconic acid and H2O2 avoiding the use of toxic H2O2. negligible biotoxicity |
|
| 22 | MSN-Au NPs | Bean-like size-500 nm | POD, OXD | 4 | 15.81 ± 0.76 mM | 12.66 ± 0.36 (10-8M· s −1) | •OH, •O2−1O2 | AB | ROS-induced oxidative stress | Antibiofilm |
|
| 23 | PdFe/GDY | Wrinkled nanosheet, size- | POD | 4 | 0.1653 mM | 0.9711 10–8 M s−1 | •OH | AB,WH | ROS-mediating bacterial cell membrane destruction | GSH activity |
|
| 24 | PEG-MoS2 NFs | Flower-like, diameter-25 nm | POD | 3–4 | 2.812 mmol L−1 | 3.88 × 10−7 | •OH | AB, wound healing | ROS and hyperthermia-mediated oxidative damage | PTT and accelerated GSH oxidation in the 808-nm laser |
|
| 25 | Co4S3/Co(OH)2 | Tube-like diameter -∼70 nm | OXD | 4 | 1.33 mM | 4.66 7–10 M/s | O2−, 1O2 | AB | ROS-induced oxidative damage | Complete sterilization without H2O2 |
|
| 26 | Cu-HCSs/H2O2 | Spherical and hollow structure diameter -∼100 nm | POD | 4.5 | — | — | •OH | AB | ROS and released Cu2+ caused membrane damage, lipid peroxidation, and DNA degradation of bacteria | Used to treat intestine infection induced by S. typhimurium |
|
| 27 | NiCo2O4-Au | Tube- like rough surface | POD, OXD | 4 | 28.33 ± 7.304 (10–3 mM) | 28.773 ± 0.103 (M/S) | •OH, •O2−, 1O2 | AB, WH | ROS-induced oxidative damage | Antibiofilm, recyclable |
|
| 28 | Co-V MMO Nanowires | Nanowire with rich surface defects | POD, OXD | 4 | 0.12 (mM) | 5.3 (10–8 M/s) | •O2, •OH | AB | ROS-induced oxidative damage | Application in the fields of new energy and catalysis |
|
| 29 | Co4S3/CO3O4 | Hollow tube-like diameter -∼166.7 nm | POD, OXD | 4 | 0.17/mM | 1.6 × 10−5/M/s | OH•, 1O2, •O2 − | AB | ROS-mediated oxidative stress | No need of H2O2, good selectivity, promising recyclability, and reliable |
|
| 30 | Fe3O4@MoS2-Ag | Defect-rich rough surface, diameter ∼428.9 nm | POD | 4 | 1.00 (mmol/L) | 1.11 (✕10−7mol/(L·s) | OH• | AB | Toxic ·OH and Ag + assisted by local hyperthermia attack the bacterial membranes | Adhesive ability Reusable | Wei et al. (2021) |
| 31 | Ir−Ag−IrO2 | Uniform and rough surface, size -90 nm | POD | 3 | 67.94 ± 3.83 μM s−1 | 0.3193 ± 0.0517 M | • OH | AB | ROS-mediated oxidative stress | More precise and selective local treatment |
|
FIGURE 5Schematic of representation of yolk-shell gold@carbon nanozymes with intrinsic enzyme mimic activity and photothermal response as an effective antitumor agent Adapted and reprinted with permission from (Fan, 2018).
List of composite nanozymes with demonstrated use as an antitumor agent through ROS.
| S. no. | Nanozyme used | Structural property of nanozyme leading to catalytic action | Catalytic property shown | Working pH of nanozyme | Km | Vmax | ROS species generate | Mechanism of action | Other specific property of nanozyme | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fe3O4@Bi2S3 | Virus-like diameter∼ 80 nm | POD | 5.5 | — | — | • OH | ROS kill cancer cells | Possesses photoacoustic and (PA) Infrared Thermal Imaging (IRT) imaging capacity. Photothermal activity under near-infrared (NIR), recyclable |
|
| 2 | AgPd@BSA/DOX | Rough core-shell branched structure, Size ∼120 nm | POD | 5.5 | — | — | • OH | Through hyperthermia with the photoreactive release of chemotherapy drug and ROS generation | Have photothermal conversion ability under NIR laser irradiation. A nanocarrier of drug doxorubicin | Li et al. (2020) |
| 3 | DMSN-Au-Fe3O4 | Central-radial pore structures, diameter ∼140 nm | POD, GOx | 6.5 | 10.10 × 10–3 m | 1.996 × 10–8 m s−1 | H2O2,• OH | ROS-induced apoptosis of cancerous cells | Excellent biosafety, easy excretion |
|
| 4 | CD44MMSN/AuNPs | Wrinkle structure, diameter ∼50 nm | POD, OXD | 3.6 | 6.35 mM | 3.85 × 10–8 Ms−1 | H2O2,•OH | ROS-mediated apoptosis | Tumor-specific precision therapy, “toxic-drug-free” and non-invasive nanocatalytic biomedicine |
|
| 5 | Au@HCNs | Spheres, diameter- 180 nm | OXD, POD | 4.5 | 0XD-0.170 mM POD-0.0323 Mm | OXD-4.92 × 10−8 POD-33.00 | ,•OH | light-enhanced ROS generation and photothermal-induced killing of cancerous cells | Excellent NIR absorbing agents for tumor PTT | Fan et al. (2018) |
| 6 | PEG-Cu2Se HNCs a | Hollow nanocube diameter- 86.89 ± 19.93 nm | POD | 7 | — | — | • OH | ROS and photothermal-mediated | Good PCE under NIR II window |
|
| 7 | Fe3O4@Pt@ E5 | Janus structure Size-(Fe3O4 8.0 ± 1.0 nm and Pt 2.0 ± 0.5 nm) | POD, OXD | 4.0 | 22.17 mM | 0.139 µMs-1 | •OH | Apoptosis by generation of ROS and block the CXCR4/CXCL12 axis | Negligible side effects |
|
| 8 | MIL-101@BSA-AuNCs NPs | Possessed good dispersibility, size -150 nm | POD | 7.4 | — | — | ·OH | By generation of ROS | Act as thermal sensitization agents under microwave radiation, possesses dual modality imaging property |
|
| 9 | NMIL-100@GOx@C | Polyhedral shape, size- 175 nm | OXD | — | — | — | H2O2 | ferroptosis and starvation treatment | Perform Fenton reaction and catalyze H2O2 (oxidase convert glucose n to gluconic acid and H2O2) produce ·OH |
|
| 10 | GOx@Pd@ZIF-8 | Irregular sphere, size-130 nm | POD | — | — | — | ·OH | By ROS-mediated apoptosis and glucose starvation | Inhibiting proliferation of cancerous cell both |
|
| 11 | CPGL (GOD, LOD, and C-dots were loaded into the hydrophobic core with the aid of PLGA.) | uniformly distributed, and granular diameters- ∼ 7–12 nm | POD | 4.55 | 0.02827 ± 0.00873 mM | 36.3782 ± 5.24999 mM s−1 | ·OH | By glucose starvation and ROS generation | pH-sensitive ability, excellent tumor-homing ability with good biocompatibility |
|
| 12 | PtFe@Fe3O4 | — | POD, CAT | 2.5–6.5 | 53.55 mM | 1.078 × 10−7 | •OH, O2 • – | Through ROS generation | Bimodal contrast agent for computed tomography (CT) and PA imaging, -guided diagnosis, Exhibit photo-enhanced catalytic activities under NIR |
|
| 13 | Fe3O4@PPy@GOD NCs | uniform with an ∼163.5 nm | POD | 6.5 | 1.59 mm | 2.64 × 10–9 M s−1 | •OH | By glucose starvation and ROS-mediated apoptosis | dual-modality diagnostic imaging-guided synergistic nanocatalytic cancer therapy and photothermal-triggered cancer hyperthermia. efficiency in NIR-I and NIR-II biowindows |
|
| 14 | N-PCNs | Porous nanospheres, size 100 ± 10 nm | POD, OXD | 4.5 | OXD-0.084 mM, POD-130 mM | OXD-0.42 10−8 M s −1, POD-32.5 10−8 M s −1 | H2O2 and •OH | By upregulation of ROS | Also possess CAT- and SOD- like activity | Fan et al. (2018) |
| 15 | MnO2@PtCo | Nanoflowers, size - 3 nm | POD, CAT | 2.5–6.8 | — | — | •OH production | ROS-mediated apoptosis | CAT activity help overcome hypoxic condition and enhance the catalytic activity of PtCo |
|
| 16 | GSF@AuNPs | 2D nanostructured, size 100–400 nm | POD | 5 | 5.980 mM | 27.7 × 10–7 M s−1 | OH• | Oxidative stress by ROS | Utilized as a selective, quantitative, and fast colorimetric detection probe for cancer cells |
|
|
| Cu2-xTe | cuboid structure, size -30 nm | Glutathione oxidase, POD | 5 | Glutathione oxidase 0.19 ± 0.03 Mm, POD-135 ± 10 Mm | Glutathionoxidase-19.3 ± 1.1 μM s−1 POD- 87 ± 0.02 | OH• | Intratumoral oxidative stress to induce immunogenic cell death | Consume GSH and exhibit photothermal activity under NIR-II Light |
|
| 18 | Fe3O4@C NPs | Core−shell structure, size -120 nm | POD | 3 | 0.38 mM | 73.99 × 10–8 M s−1 | • OH | ROS-mediated oxidative stress | Selectively, magnetic responsiveness and receptor-binding specificity |
|
| 19 | Magnetic hydrogel nanozyme (MHZ) | Spherical core−shell structure, size 30–50 nm | POD | 5.2 | — | — | • OH | Oxidative stress damages the protective heat shock protein 70 | Powerful platform for combination with hyperthermia and catalytic therapy |
|
| 20 | HCS@Pt-Ce6 | — | POD, OXD | 4.5 | POD-0.04853 mM, OXD-0.352 mM | POD-21.7871 10−8 M⋅s−1, OXD-0.8243 10−8 M⋅s−1 | • OH | ROS and photodynamic mediated apoptosis | Synergistic photodynamic-catalytic therapy of tumor |
|
| 21 | AuPt@SF (APS) | Intriguing nonregular polyhedral structure, Size ∼36 nm68.71 ± 32.8 nm | GOx, POD. | 5.5 | POD-28.148 mM, GOx45.795 μg/ml | POD-6.756, GOx -0.125 μM/s | O2—and •OH | Through deleterious tumor starvation and irreversible oxidative-stress destruction | GSH depletion |
|
| 22 | CoO@AuPt | Hollow, diameter ∼36 nm | OXD, POD | GOx -6.5, POD and CAT-6.8 | — | — | O2,•OH H2O2 | ROS and glucose starvation–mediated inhibition of tumor | Also possess CAT activity |
|
| Deplete Glutathione | ||||||||||
| 23 | UMOFs@ Au NPs | Core shell structure size-29.8 ± 2.2 nm | OXD | 4.5 | 44.27 mM | 12.96 × 10–7 M s−1 | H2O2 and1 O2 | Glucose starvation and ROS mediated | PDT effects under NIR light irradiation |
|
| 24 | PEG/Ce-Bi@DMSN | Bacteria like | POD, CAT | 5.5 | 27.54 × 10–3 m | 3.85 × 10–8 m s−1 | • OH | impaired the antioxidant defenses of tumor cells and causes oxidative stress | Deplete GSH, and also Act as PTT agent in the NIRII- biowindow |
|